Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis

Vascular dementia (VaD) is the second commonest type of dementia which lacks of efficient treatments currently. Neuroinflammation as a prominent pathological feature of VaD, is highly involved in the development of VaD. In order to verify the therapeutic potential of PDE1 inhibitors against VaD, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Le, Meiling, Yang, Yiyi, Wang, Wenjuan, Huang, Yuqi, Wang, Quan, Tian, Yijing, Jiang, Meiyan, Rao, Yong, Luo, Hai-Bin, Wu, Yinuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031254/
https://www.ncbi.nlm.nih.gov/pubmed/36970192
http://dx.doi.org/10.1016/j.apsb.2022.09.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031254/
https://www.ncbi.nlm.nih.gov/pubmed/36970192
http://dx.doi.org/10.1016/j.apsb.2022.09.023

Ejemplares similares